Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 5, 2000, Pages 58-68

  Parfrey, P S ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERINDOPRIL; SODIUM CHLORIDE; WATER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY BURDEN; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; ECHOCARDIOGRAPHY; FEMALE; FLUID INTAKE; HEART DISEASE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SODIUM RESTRICTION; TREATMENT OUTCOME;

EID: 0033790493     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_5.58     Document Type: Article

References (55)

1. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
2. The clinical epidemiology of cardiac disease in chronic renal failure
3. Controlling the epidemic of cardiovascular disease in chronic renal disease
4. Cardiac disease in dialysis patients: Uremia related risk factors
5. Outcome and risk factors of ischaemic heart disease in chronic uremia
6. Cardiac disease in diabetic end-stage renal disease
7. Cardiac disease in chronic uremia: Pathogenesis
8. Cardiac and arterial interactions in end-stage renal disease
9. The outcome and risk factors for left ventricular disorders in chronic uremia
10. The reliability and validity of echocardiographic measurement of left ventricular mass in hemodialysis patients
11. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis, and risk factors
12. Dialysis ischaemic heart disease: Insights from coronary angiography
13. Pathogenesis of cardiac disease in dialysis patients
14. Screening for cardiovascular disease in dialysis patients
15. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients
16. Left ventricular dysfunction in endstage renal disease: Echocardiographic insights
17. Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation
18. USRDS dialysis morbidity and mortality study: Wave 2
19. Prediction of early death in end stage renal disease patients receiving dialysis
20. Trends in comorbidity and residual renal function in patients starting treatment for endstage renal disease
21. Canadian hemodialysis morbidity study
22. Mode of dialysis therapy and mortality in end-stage renal disease
23. Report on management of renal failure in Europe, XXII, 1991
24. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis
25. Long-term evolution of cardiomyopathy in dialysis patients
26. The prognostic importance of left ventricular geometry in uremic cardiomyopathy
27. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
28. Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus
29. Left ventricular mass in diabetes-hypertension
30. A comparison of the pathological spectrum of hypertensive, diabetic and hypertensive-diabetic heart disease circulation
31. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
32. Left ventricular mass increase in early renal disease: Impact of decline in hemoglobin
33. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients
34. Residual renal function and recovery of renal function in patients treated by CAPD
35. CAPD viability: A long-term comparison with hemodialysis
36. Impact of hypertension on cardiomyopathy, morbidity and mortality in end stage renal disease
37. Hypoalbuminemia, cardiac morbidity and mortality end stage renal disease
38. Malnutrition, cardiac disease and mortality-an integrated point of view
39. The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease
40. Screening and treatment for cardiovascular disease in patients with chronic renal disease
41. Hyperlipidemia in patients with chronic renal disease
42. Abnormalities of lipoprotein metabolism in CAPD patients
43. Hypocalcemia, morbidity, and mortality in endstage renal disease
44. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
45. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia
46. Parathyroid function and lipid metabolism in the rat
47. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial parathyroidectomy
48. Effect of parathyroid hormone on rat heart cells
49. The role of parathyroid hormone in the genesis of interstitial cell activation in uremia
50. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
51. Cardiae hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade
52. A randomized controlled trial of complete vs partial correction of anemia in hemodialysis patients with a symptomatic concentric LV hypertrophy or LV dilatation
53. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
54. Effect of intensive diabetes management on macro-vascular events and risk factors in the diabetes control and complications trial